MHS News

The visit demonstrated the strategic role that regional diagnostic manufacturing can play in ensuring reliable access to medical supplies like RDTs while advancing Africa’s broader goals of health security,

Prof. Dr. Alexzander Asea, Chief Executive Officer of the Vaccine Access Initiative (VAI) a subsidiary of Microhaem Scientifics (MHS) was elected to the Board of the African Vaccine Manufacturing Initiative (AVMI),

Microhaem Scientifics (MHS) was honored to host the senior leadership of Equity Bank Kenya and Equity Bank Uganda for a high-level courtesy engagement

The Mustard Seed Awards 2025 were held on January 24, 2026, at the Inspire Africa Coffee Park in Rwashamire, Nyabihoko, Ntungamo District, Uganda.

Microhaem Scientifics (MHS) was honored to host a high-level delegation from the Republic of South Sudan at its In Vitro Diagnostics (IVD) manufacturing facility in Ntinda, Kampala.

At Microhaem Scientifics (MHS), gratitude and purpose guide our mission to save lives through quality diagnostics. We are deeply grateful to God for this progress and the vision that continues to shape our journey.

As Africa charts a bold course toward health sovereignty, partnerships, leadership engagements, and continental collaboration are becoming increasingly vital.

A standout moment came from Microhaem Scientifics (@Microhaem), East Africa’s pioneering medical manufacturing firm, established in 2012 as the region’s first indigenous producer of in-vitro diagnostic (IVD) test kits.

Microhaem Scientifics has officially embarked on a facelift of its Administration Block located at Martyrs Way, Ntinda, Kampala.